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Canine monocytic ehrlichiosis (CME) is a tick-
borne disease enzootic in the African continent,
caused by the bacteria Ehrlichia canis. The patho-
genesis of the disease involves an incubation
period of 8–20 days, followed by three consecu-
tives phases: acute, subclinical, and sometimes
chronic [1]. Infected dogs with a subclinical or a
mild asymptomatic chronic stage of CME could
be considered as reservoirs for the pathogen,
hence the importance of screening animals as a
preventive measure. The objective of our study
was to determine the seroprevalence of E. canis
among apparently healthy dogs in Africa (Gabon
and the Ivory Coast), and compare their biochem-
ical data with their serological status.
The study was carried out in 187 apparently
healthy working dogs belonging to surveillance
companies in Abidjan (n = 76) and in Libreville
(n = 111). Dogs from Abidjan (64% males and
36% females) were between 9 months and
12 years old, with an average of approximately
3.8 years. Dogs from Libreville (58% males and
42% females) were between 11 months and
15 years old, with an average of approximately
3.9 years. The dogs didn’t have any anti-infection
treatment. Blood was collected from the cephalic
vein, samples were centrifuged and the serumwas
submitted for biochemical analysis, or stored at
)20C for serology. Serum samples were assayed
for antibodies to E. canis using the reference
method, i.e., indirect ﬂuorescent antibody test
(IFAT). Titres ‡1 ⁄ 80 were considered as positive
[2]. Seropositive dogs were divided into two
subgroups: low and medium titres (1 ⁄ 80–1 ⁄ 1280)
and high titres (‡1 ⁄ 2560). Seronegative dogs were
used as the control group.
Catalytic concentrations of aspartate amino-
transferase, alanine aminotransferase and alkaline
phosphatase were determined on a COBAS INTE-
GRA 800 analyser (Roche Diagnostics, Meylan,
France), using the method recommended by the
International Federation of Clinical Chemistry.
Serum proteins were separated by electrophoresis
with the semi-automated HYDRASYS instrument.
The electrophoretograms were evaluated visually
for pattern abnormalities. The different groups
were compared with each other, for each param-
eter, using the f-test or analysis of variance
(ANOVA), and non-parametric tests when Bartlett’s
test indicated heterogeneous variances and ANOVA
was not appropriate. All statistical tests were
carried out using the Epi Info Software (CDC,
Atlanta, GA, USA). Statistical signiﬁcance was
deﬁned as p <0.05.
IFA tests showed that 80% (149 ⁄ 187) of the sera
were reactive with E. canis antigens at a dilution of
1 ⁄ 80 or above. The 74% (56 ⁄ 76) seroprevalence in
dogs from Abidjan was not signiﬁcantly different
from the 84% (93 ⁄ 111) in dogs from Libreville
(p 0.1). No correlation was found between E. canis
antibody titres and age or sex (p 0.6 and 0.14,
respectively). Table 1 shows blood biochemi-
cal parameters (mean ± standard deviation) in
E. canis seropositive and seronegative dogs, as
well as summarised comparisons between sero-
negative, low or medium seropositive, and high
seropositive dogs. Certain intrinsic factors, such as
age and sex, may cause variations in serum
protein concentrations, but no signiﬁcant inﬂu-
ence of these parameters was shown here.
The very high seroprevalence (80%) of E. canis
may be explained by the fact that dogs lived in a
biotope favourable to the development of its
vector, Rhipicephalus sanguineus. The life condi-
tions of dogs housed together also favour the
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transmission of the infection. Animals included in
our study were apparently in good health. Sero-
positive dogs were assumed to be in a subclinical
or chronic asymptomatic phase of CME, or to have
eliminated E. canis while retaining an aberrant
immune response. It is difﬁcult to explain the high
prevalence of asymptomatic ehrlichiosis without
assuming that the canine population acquires
some degree of immunity due to close and
repeated contacts with the antigen. Recent studies
suggest that dogs infected with E. canis develop an
immune response that does not protect them
against re-infection and does not reduce clinical
signs [3]. Infected dogs may act as a source of
infection. The control of canine monocytic ehrlich-
iosis must take into account this role of healthy
carriers and include prophylactic measures.
The infected dogs were found to have a
signiﬁcant hypoalbuminaemia, hyperglobulina-
emia and hypergammaglobulinaemia compared
with the control dogs, and there may be a link
between the deterioration of biochemical param-
eters and the rise in anti-E. canis antibodies.
Studies have shown that in dogs with asymptom-
atic ehrlichiosis, hypergammaglobulinaemia
results mainly from a rise in G gammaglobulins.
In the different phases of symptomatic and
asymptomatic ehrlichiosis, IgG2 are predominant
in the humoral immune response compared with
IgG1 [4]. The literature does not describe hyper-
gammaglobulinaemia as being directly related to
the titre of anti-E. canis antibodies determined by
IFAT, but these studies were carried out on a
smaller number of dogs, mostly in the acute phase
of the disease [5]. In our study, gammaglobulin
concentrations were signiﬁcantly elevated
(p <0.0001) in dogs with a high titre compared
with the other seropositive animals, and we found
that there was a connexion between the produc-
tion of antibodies and gammaglobulin blood
levels.
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Table 1. Blood biochemical parameters (mean ± standard deviation) in Ehrlichia canis seropositive and seronegative dogs
(indirect ﬂuorescent antibody test) and statistically signiﬁcant differences between dog groups (variance analysis)
Parameters
Seronegative
n = 38
Seropositive
n = 149
Low and medium
seropositive
[1 ⁄ 80–1 ⁄ 1280]
n = 53
High
seropositive
‡1 ⁄ 2560
n = 96 Results of statistical comparison of the means
Aspartate amino-transferase 28 ± 8 29 ± 14 33 ± 17 26 ± 12 c (p <0.005), but still within the normal range (30–50 U ⁄L)
Alanine amino-transferase 32 ± 20 27 ± 26 36 ± 27 22 ± 24 b, c (p <0.05 and <0.001), but still within the normal range (<80 U ⁄L)
Alkaline phosphatases 40 ± 31 47 ± 74 45 ± 80 48 ± 71 No signiﬁcant differences
Total serum protein 72.3 ± 8.4 79.4 ± 10.8 76.5 ± 9.2 81 ± 11.3 e, f (p <0.0005, <0.0001) and g, h (p <0.05)
Albumin ⁄Globulin ratio 0.8 ± 0.3 0.6 ± 0.2 0.7 ± 0.3 0.5 ± 0.2 a, b, c (p <0.0001) and d (p <0.05)
Albumin 32 ± 5 27.5 ± 6.4 31 ± 6 25.5 ± 5.7 a, b, c (p <0.0001)
Alpha 1 globulin 2.7 ± 0.3 2.8 ± 0.5 2.7 ± 0.4 2.8 ± 0.5 No signiﬁcant differences
Alpha 2 globulin 9.9 ± 1.7 10.1 ± 1.7 10.1 ± 1.7 10.1 ± 1.6 No signiﬁcant differences
Beta globulin 19.1 ± 6.4 22.5 ± 6.9 22.5 ± 7.4 22.5 ± 6.6 e, h (p <0. 01 and <0.05)
Gamma globulin 8.7 ± 5 16.6 ± 11 10.1 ± 6.4 20.1 ± 11.4 e, f, g (p <0.0001)
a = signiﬁcantly lower in seropositive dogs compared with seronegative dogs.
b = signiﬁcantly lower in dogs with high titres compared with seronegative dogs.
c = signiﬁcantly lower in dogs with high titres compared with dogs with low or medium titres.
d = signiﬁcantly lower in dogs with medium titres compared with seronegative dogs.
e = signiﬁcantly elevated in seropositive dogs compared with seronegative dogs.
f = signiﬁcantly elevated in dogs with high titres compared with seronegative dogs.
g = signiﬁcantly elevated in dogs with high titres compared with dogs with low or medium titres.
h = signiﬁcantly elevated in dogs with medium titres compared with seronegative dogs.
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